Preventing COPD exacerbations with macrolides: a review and budget impact analysis--author response to letter to the editor.
KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, 3000 Leuven, Belgium. Electronic address: steven.simoens@pharm.kuleuven.be.
Steven
S
Simoens
KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, 3000 Leuven, Belgium.
Gert
G
Laekeman
University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
Marc
M
Decramer
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D018942:Macrolides